The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 07, 2025

Filed:

Sep. 24, 2019
Applicant:

University of Manitoba, Winnipeg, CA;

Inventors:

Francis Lin, Winnipeg, CA;

Jiandong Wu, Winnipeg, CA;

Claudio Rigatto, Winnipeg, CA;

Paul Komenda, Winnipeg, CA;

Navdeep Tangri, Winnipeg, CA;

Gong Zhang, Winnipeg, CA;

Assignee:

University of Manitoba, Winnipeg, CA;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
B01L 3/00 (2006.01); G01N 21/78 (2006.01); G01N 33/68 (2006.01); G01N 33/70 (2006.01);
U.S. Cl.
CPC ...
B01L 3/502776 (2013.01); G01N 21/78 (2013.01); G01N 33/6839 (2013.01); G01N 33/70 (2013.01); B01L 2300/0867 (2013.01); B01L 2300/0883 (2013.01); B01L 2400/0457 (2013.01); G01N 2333/76 (2013.01); G01N 2800/347 (2013.01);
Abstract

Described herein is a method for mixing unequal amounts of two reagents to produce a detectable reaction in a microfluidic chip. In one example, there is a fluorescent microfluidic urinary albumin chip (UAL-Chip) that exploits the nonimmunological fluorescent assay. In this chip, we constructed a passive and continuous mixing module, in which the loading process requires only an inexpensive dropper, and the signal is stable over time, as discussed below. We applied a pressure-balancing strategy based on the immiscible oil coverage which highly improves the precision in controlling the mixing ratio of sample and dye. The UAL-Chip has achieved an estimated limit of detection (LOD) of 8.4 μg/ml using albumin standards, which is below the 30 μg albumin per ml urine level considered to be indicative of kidney damage.


Find Patent Forward Citations

Loading…